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Abstract
Background: We assessed the severity of the 2009 influenza pandemic by comparing pandemic mortality to seasonal
influenza mortality. However, reported pandemic deaths were laboratory-confirmed – and thus an underestimation –
whereas seasonal influenza mortality is often more inclusively estimated. For a valid comparison, our study used the same
statistical methodology and data types to estimate pandemic and seasonal influenza mortality.
Methods and Findings: We used data on all-cause mortality (1999–2010, 100% coverage, 16.5 million Dutch population)
and influenza-like-illness (ILI) incidence (0.8% coverage). Data was aggregated by week and age category. Using generalized
estimating equation regression models, we attributed mortality to influenza by associating mortality with ILI-incidence,
while adjusting for annual shifts in association. We also adjusted for respiratory syncytial virus, hot/cold weather, other
seasonal factors and autocorrelation. For the 2009 pandemic season, we estimated 612 (range 266–958) influenza-attributed
deaths; for seasonal influenza 1,956 (range 0–3,990). 15,845 years-of-life-lost were estimated for the pandemic; for an
average seasonal epidemic 17,908. For 0–4 yrs of age the number of influenza-attributed deaths during the pandemic were
higher than in any seasonal epidemic; 77 deaths (range 61–93) compared to 16 deaths (range 0–45). The $75 yrs of age
showed a far below average number of deaths. Using pneumonia/influenza and respiratory/cardiovascular instead of all-
cause deaths consistently resulted in relatively low total pandemic mortality, combined with high impact in the youngest
age category.
Conclusion: The pandemic had an overall moderate impact on mortality compared to 10 preceding seasonal epidemics,
with higher mortality in young children and low mortality in the elderly. This resulted in a total number of pandemic deaths
far below the average for seasonal influenza, and a total number of years-of-life-lost somewhat below average. Comparing
pandemic and seasonal influenza mortality as in our study will help assessing the worldwide impact of the 2009 pandemic.
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Introduction
The 2009 influenza A/H1N1 pandemic has led to major
additional surveillance and control efforts by public health
authorities worldwide. Assessing the severity of the pandemic has
been complicated. A concrete measure of severity would be the
number of deaths (mortality) and years-of-life-lost due to the
pandemic compared to the numbers caused by seasonal epidemics.
However, the numbers of pandemic deaths reported to WHO
[1,2] were only those that were laboratory-confirmed and thus
underestimate true numbers. These laboratory-confirmed figures
cannot, therefore, be directly compared to seasonal influenza
mortality estimates which – other than the pandemic deaths
reported to WHO – are often based on statistical attribution of all-
cause mortality to influenza [3,4,5]. To properly compare the
2009 pandemic mortality to seasonal influenza, the same statistical
methodology should be used.
Another methodological issue is that young children seem to
have been disproportionately affected by the pandemic, whereas
the elderly have been relatively spared [6,7,8]. As years-of-life-lost
decrease with increasing age of death, a proper comparison
between pandemic and seasonal influenza should take into
account the age distribution of fatal cases.
Two studies have estimated age-specific pandemic and seasonal
influenza mortality for the US [9] and Australia [10], by
attributing all-cause mortality to influenza if it deviated from a
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31197
seasonal baseline, similar to earlier studies that estimated seasonal
influenza mortality [3,4,5]. This approach assumes that all
mortality deviations from the seasonal baseline during influenza
epidemics are due to influenza. An alternative way to attribute all-
cause mortality to influenza is using the modeled association of all-
cause mortality and influenza activity in the population. In the
Netherlands and many other countries, fluctuations of influenza
activity in the population are reflected by the weekly influenza-
like-illness (ILI) incidence as available from a sentinel network of
general practitioners [11].
Nevertheless, associating all-cause mortality to ILI-incidence
can be complicated by annual heterogeneity in the association
between mortality and ILI. In an earlier study we already reported
that such annual heterogeneity in association is likely to be due to
differences in severity per ILI case driven by viral factors such as
dominant (sub)types (influenza A(H1N1), A(H3N2) or B) and/or
antigenic characteristics [12], but some heterogeneities may also
be caused by media attention and public anxiety. This problem
can be solved by allowing the modeled association of mortality
with ILI to vary among years [12].
In this study we compared the 2009 pandemic mortality to the
10 preceding seasonal epidemics in the Netherlands (population
size 16.5 million) by attributing age-specific all-cause mortality to
influenza in 1999–2010, using the modeled association of weekly
all-cause mortality with ILI-incidence. We also calculated years-of-
life-lost from the age-specific influenza mortality estimates.
Methods
Mortality and influenza surveillance data
We obtained weekly mortality data from Statistics Netherlands
(100% coverage) for the period 1999–2010, aggregated by week
and age category (0–4, 5–24, 25–44, 45–64, 65–74 and $75 yrs of
age). In addition to all-cause mortality, physician-reported primary
cause of death data were available for analysis. Weekly ILI-
incidence data for 1999–2010 were obtained from a sentinel
network of general practitioners (GP-ILI data, 0.8% coverage)
[11]. See Figure S1 for the time series of mortality by age category
and ILI incidence. For analysis, successive years were defined to
start on July 1st and to end on June 30th, since influenza epidemics
normally occur around wintertime.
Data on laboratory detections
To adjust for possible mortality caused by pathogens other than
influenza, we also investigated total weekly counts of RSV, as
reported by a routine laboratory surveillance system (the Weekly
Diagnostic Laboratory Reports of the Dutch Working Group on
Clinical Virology, which covers 38–73% of viral diagnostics in the
Netherlands; number of laboratory submissions (denominator) and
patient age were not available [13]). As RSV is known to cause
severe morbidity, especially in young children but also in adults
[14,15], it might affect estimates of influenza-associated mortality.
During the pandemic, substantially more RSV infections were
detected than in earlier years, probably due to increased requests
for RSV diagnostics to exclude influenza. Such an artifact could
bias estimates of the association of RSV with mortality. Therefore,
we adjusted the RSV data during the pandemic downward by
dividing the counts in 2009/2010 by a factor that reduces the total
annual count to the mean annual count during the 4 years before
2009/2010. From the same laboratory network, weekly counts of
influenza detections were also available as an alternative measure
for influenza activity (instead of ILI-incidence) in a sensitivity
analysis.
Temperature data
Another contributor to (excess) mortality can be weather
conditions, such as hot and/or cold temperatures [16,17].
Therefore, we also calculated the weekly mean temperature from
reported daily mean temperatures for 1999–2010 (www.knmi.nl)
and defined weight variables for cold or warm weeks as the
number of degrees Celsius below 0uC and above 17uC
respectively.
Regression analyses
Similar to [12], we used additive generalized estimating
equation (GEE) [18] models with a Poisson distribution to
attribute all-cause mortality to ILI-incidence. We decided to use
the overall (instead of age-specific) ILI-incidence, because the
coverage in the GP-ILI-sentinel may have been insufficient for
some of the age categories included in the study. Thus we
considered the overall ILI-incidence as a measure of influenza
activity on the national level, associated with all-cause mortality by
age category. As fluctuations in ILI-incidence may to some extent
reflect activity of pathogens other than influenza, we only included
the ILI-incidence within a 23/+3 week window around influenza
epidemic episodes (defined as two or more successive weeks that
the overall weekly ILI-incidence was above the threshold for
influenza epidemics; i.e. 5.1 per 10,000 population [11]); in other
weeks the ILI incidence was truncated at zero. First, we regressed
mortality time series – separately for each age category – on
(lagged) overall ILI-incidence, using a generalized linear model
with a Poisson distribution and an identity link. To correct for
mortality due to seasonal factors other than influenza, we started
with a constant basic mortality level plus sine and cosine variables
(sine(k2pweek/52) and cosine(k2pweek/52), k = 1,2,3,4). We also
added the temperature variables as covariables to correct for
mortality due to hot (mean daily temperature.17uC) and/or cold
(mean daily temperature,0uC) weather conditions. We then
added the ILI-incidence and the RSV counts to the model,
selecting the lagged ILI and RSV variable that contributed most to
the model fit (-4 up to +2 week lags were considered for inclusion;
e.g., in step 1, ILI was included with a 1-week lag if that exhibited
a better model fit than all other ILI/RSV-lag combinations,
assessed with Akaike’s information criterion [19]). We included
lagged GP-ILI-incidence and the RSV counts in the model only
once (i.e. for one lag). We used year-specific ILI regression
coefficients as described in [12] so that the modeled association of
mortality with ILI can vary among years. Essentially, these year-
specific ILI regression coefficients are scaling factors for the
number of deaths associated with a one-case increase in ILI-
incidence per 10,000 population. Finally, we used GEEs [18] to
correct the model outcomes for autocorrelation between observa-
tions. See Appendix S1 for details on the regression models.
We then used the model coefficients to estimate the weekly
number of ILI-attributed deaths by age category. Based upon
these weekly estimates of influenza-attributed deaths, we calculat-
ed the annual influenza-attributed numbers of deaths, scaled to the
2009 population. Finally, we compared the pandemic mortality to
the influenza mortality in earlier years.
We also performed a sensitivity analysis to evaluate the impact
of our model choices on the influenza-attributed mortality; we
evaluated the impact of in- or excluding RSV or the hot/cold
weather variables in the model, using ILI-incidence vs influenza
detections as a measure of influenza activity, and using
pneumonia/influenza (ICD-10 codes J09-J18) or respiratory/
cardiovascular (J00-J99 and I00-I99) deaths as explained variables
instead of all-cause deaths.
Comparing Pandemic to Seasonal Influenza Mortality
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Years-of-life-lost
We calculated the years-of-life-lost (YLL) [20] by multiplying
each death with the residual life expectancy of its age group, which
was derived from 2009 Dutch mortality data, as described in [21].
The residual life expectancy per age group was weighted by the
average age of death in that group (Table 1).
Results
Regression analysis
Fitting the regression models with annual ILI-coefficients to our
data showed heterogeneity in the influenza-attributed mortality
incidence both among years, and among age categories. Figure 1a–
b illustrates this heterogeneity for the 0–4 and $75 yrs of age; for
the 0–4 yrs of age there is a sharp elevation in the influenza-
attributed mortality during the pandemic, whereas for the elderly
this mortality is minimal compared to earlier years.
In the models, for all age categories the (lagged) ILI-incidence
was included as explanatory variable for all-cause mortality. The
annual ILI regression coefficients showed significant heterogeneity
between years for all age categories (F-test, P#0.0001). Some of
the annual ILI regression coefficients estimates were below zero –
reflecting the mild influenza impact in those years, as also observed
in [12] – and were truncated at zero.
Influenza-attributed mortality and years-of-life-lost
Table 2 shows the annual influenza-attributed mortality per age
category, as well as the overall annual influenza mortality and
years-of-life-lost. For the pandemic, a total of 612 deaths (95% CI
266–958) were attributed to influenza, corresponding to 3.70
deaths (1.61–5.79) per 100,000 population. This is much lower
than the mean 1,956 annual deaths for seasonal influenza (Table 2;
corresponding to 11.83 deaths per 100,000 pop.); however, the
number of years-of-life-lost for the pandemic was estimated at
15,845, which comes close to the mean 17,908 years-of-life-lost for
seasonal influenza (although for 6 out of 10 seasonal epidemics
more years-of-life-lost were estimated than for the pandemic,
Table 2).
Figure 2 further illustrates the difference in impact by number of
deaths (Figure 2a) or years-of-life-lost (Figure 2b). For the 0–4 yrs
of age – the category with the highest residual life expectancy – the
number of influenza-attributed deaths during the pandemic was
higher than in any seasonal epidemic in the study period (Table 2
and Figure 2a). For the age categories 5–24, 25–44, 45–64 and
65–74 yrs of age, some seasonal epidemics show higher and others
lower numbers of deaths in these age categories than during the
pandemic. Finally, the $75 yrs of age have a far below average
number of deaths during the pandemic. The numbers of pandemic
deaths by age category in Table 2 and Figure 2a correspond to a
population rate of 8.30 (95% CI 6.58–10.03) pandemic deaths per
100,000 in 0–4 yrs of age; 0.76 (0.32–1.19) in 5–24 yrs; 0.65 (0–
1.29) in 25–44 yrs; 1.00 (0–2.64) in 45–64 yrs; 22.79(16.92–28.67)
in 65–74 yrs; and 10.27 (0–39.04) in $75 yrs of age.
Sensitivity analysis showed that RSV and hot/cold weather only
minimally influenced the influenza-attributed mortality. Replacing
ILI-incidence by influenza detections in the models did not change
the estimates much either. When replacing all-cause mortality by
respiratory/cardiovascular or pneumonia/influenza deaths, the
estimates for pandemic and seasonal influenza deaths were much
lower; but pandemic mortality was consistently estimated lower
than during an average seasonal influenza epidemic, with a
relatively low impact in the elderly combined with a relatively high
impact in the youngest age category. See Appendix S2 for further
details.
Because of the increased number of influenza-attributed deaths
in the 0–4 yrs of age during the pandemic year, we further
explored the distribution of age and reported cause of death in this
age category. After excluding neonatal deaths, deaths at ,1 yrs of
age occurred relatively more often during the pandemic than in
earlier seasonal influenza years (right-sided Fisher’s exact tests for
262 tables; P#0.022), but to a lesser extent this was also observed
for the seasonal epidemic in 2000/2001. Among the reported
causes of death, cardiomyopathy (International Classification of
Diseases, 10th revision, ICD-10 code I42) and spinal muscular
atrophy (ICD-10 code G12.9) were overrepresented during the
pandemic exclusively (P#0.002 and P#0.012 respectively).
Intracerebral haemorrhage in neonates was also disproportion-
ately high during the pandemic (ICD-10 P52.4; P#0.004), but also
in 2004/2005 although then only borderline significant. The two
other causes of death that showed elevations (fetus/newborn with
necrotizing enterocolitis and fetus/newborn affected by multiple
pregnancy, ICD-10 P77 and P01.5) seemed unlikely to be related
to the pandemic, since the first had been increasing since 2007 and
the second showed elevations for two other years in the study. See
Appendix S3 for further details.
Discussion
By comparing mortality estimates of the 2009 pandemic with
those for seasonal influenza, we found that deaths in young
children disproportionately contributed to the number of pan-
demic deaths compared to seasonal influenza. However, the
overall pandemic impact was only moderate with the total years-
of-life-lost somewhat below but close to the average of seasonal
influenza, and the total number of deaths far below average. This
limited impact – despite disproportionate mortality in young
children – was mainly due to low mortality in the elderly ($75 yrs
of age) compared to most seasonal epidemics.
Comparing pandemic vs seasonal influenza mortality
We were able to compare pandemic to seasonal influenza
mortality by using the same statistical methodology and data types
for both pandemic and seasonal influenza years. Our use of annual
instead of constant ILI-coefficients made it possible to estimate the
influenza-attributed mortality per year, adjusted for shifts in the
association of ILI-incidence and mortality.
We found a large range of total numbers of deaths and years-of-
life-lost for the 10 seasonal epidemics. In 2003/2004 the influenza
A/Fujian/411/02(H3N2) drift variant emerged and Fujian-like
H3N2 viruses remained the dominant subtype in the next 3 years
[22]; not surprisingly, we observed high seasonal influenza
mortality in 2003/2004 and 2004/2005. However, over the
Table 1. Life expectancy estimates in the Netherlands used
for calculation of years-of-life-lost (YLL).
Age group
Average age at
death in 2009 (yrs)
Life expectancy
in 2009 (yrs)
0–4 0.62 80.26
5–24 17.93 63.23
25–44 38.13 43.44
45–64 57.63 25.33
65–74 70.43 14.93
$75 85.65 5.52
doi:10.1371/journal.pone.0031197.t001
Comparing Pandemic to Seasonal Influenza Mortality
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Figure 1. Weekly estimates for ILI-attributed mortality for the (a) 0–4 and (b) $75 yrs of age (data for other age categories not
shown). For these estimates we used regression models with annual ILI-coefficients, corrected for RSV activity, hot/cold weather, seasonal factors
and a time trend. The green colored areas reflect the estimated ILI-attributed mortality, and the black dotted lines present the actually observed
Comparing Pandemic to Seasonal Influenza Mortality
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following 2 years - with still Fujian-like H3N2 viruses as the
dominant subtype - we observed a sharp decline in influenza-
attributed mortality (Table 2); this decrease in mortality impact
may be due to increasing population immunity over the years by
successive natural infection and vaccination with A(H3N2) viruses
of similar antigenicity. For the other seasonal epidemics, the years
with H3N2 subtypes as dominant viruses (1999/2000, 2001/2002,
2008/2009) showed relatively high mortality, whereas the H1N1
seasons (2000/2001, 2007/2008) showed relatively low mortality,
which seems in line with the fact that mortality levels tend to be
lower in seasons with predominantly A(H1) strains than in A(H3)
seasons [23,24]. The mortality during the two H1N1 seasonal
epidemics appears to be especially low in older age groups, as also
observed for the 2009 pandemic; this may be due to relatively high
(memory) immunity for H1N1 viruses in people born before 1957,
induced by viruses descending from the 1918/1919 pandemic
virus, as has been reported for the 2009 pandemic [25].
Disproportionate mortality in young children
For the 0–4 yrs of age, we estimated 77 pandemic deaths, which
is higher than for any seasonal influenza epidemic in the study.
Remarkably, in the Netherlands only 5 laboratory-confirmed
deaths in 0–4 yrs of age were reported during the pandemic,
including one child ,1 yrs of age with a medical condition
[26,27]. This low number of laboratory-confirmed pediatric
deaths, compared to the 77 estimated pandemic deaths in this
study, raises the question whether pediatric deaths due to
pandemic influenza may have gone unrecognized. Alternatively,
the high number of influenza-attributed deaths in young children
during the pandemic may be spurious, due to a rise in deaths by
other causes at the same time. However, to our knowledge there
were no other unusual competing events or epidemics that may
explain such an increase in deaths in young children.
The higher proportion of deaths in ,1 yrs of age (excluding
neonates) that we observed, suggests that a disproportionate
fraction of the 77 estimated influenza-attributed deaths may have
occurred in infants ,1 yrs of age who may be less likely to show
sufficiently specific symptoms of influenza infection to prompt
requests for influenza laboratory diagnostics. In England and
Argentina, high mortality rates in infants have been reported
among pediatric deaths due to laboratory-confirmed influenza
A(H1N1) 2009 infection [28,29]. For Australia and the US, studies
that attributed all-cause mortality to influenza did not report many
deaths in infants [9,10]; for the Australian study, infant deaths
were subsumed under the 0–19 yrs of age category and thus excess
infant mortality may have been unrecognized; in the US study,
age-specific mortality estimates were extrapolated from the age
distribution of laboratory-confirmed deaths, so mortality in infants
would only have been picked up after laboratory confirmation.
However, in two recent studies also attributing age stratified all-
cause mortality to influenza – including 0–4 yrs of age as in our
study – no increased mortality in 0–4 yrs of age was observed for
Denmark and Mexico [30,31]; estimates for several other age
categories were also different, and all-age pandemic mortality was
weekly mortality; the orange colored areas reflect the estimated basis seasonal mortality, corrected for a time trend; the brown and red colored areas
reflect mortality attributed to RSV and hot/cold weather conditions respectively. The grey-shaded bars on the background of the graphs indicate
influenza epidemic episodes (defined as 23/+3 weeks around successive weeks with an overall ILI-incidence $5.1/10,000 population); only ILI-
incidence in these episodes was included in the models. The strong downward timetrend in 0–4 yrs of age seems mainly due to a decrease of 39% in
neonatal deaths in the last decade as reported by the national perinatal audit [45].
doi:10.1371/journal.pone.0031197.g001
Table 2. Annual influenza-attributed deaths and years-of-life-lost (YLL) by age category.
Number of influenza-attributed deaths YLL
By age category Total
0–4 5–24 25–44 45–64 65–74 $75
Seasonal
influenza
1999/2000 4 (0–11) 0 (0–2) 13 (0–36) 60 (14–106) 291 (182–400) 2,310 (1,891–2,730) 2,679 (2,234–3,108) 19,512
2000/2001 37 (29–45) 38 (28–48) 12 (0–37) 0 (0–0) 0 (0–13) 0 (0–279) 87 (0–183) 5,906
2001/2002 19 (10–29) 22 (7–37) 30 (0–70) 142 (76–209) 222 (73–372) 2,257 (1,673–2,840) 2,693 (2,085–3,301) 23,650
2002/2003 0 (0–0) 21 (12–31) 10 (0–41) 176 (128–224) 328 (230–426) 1,716 (1,361–2,070) 2,251 (1,859–2,604) 20,614
2003/2004 24 (18–30) 3 (0–13) 62 (36–89) 233 (193–273) 393 (314–472) 2,232 (1,920–2,543) 2,947 (2,622–3,271) 28,933
2004/2005 29 (24–34) 20 (7–33) 41 (14–68) 170 (117–222) 205 (123–286) 3,170 (2,829–3,511) 3,634 (3,278–3,990) 30,243
2005/2006 15 (8–22) 15 (0–31) 0 (0–21) 8 (0–73) 0 (0–0) 1,096 (661–1,532) 1,134 (435–1,341) 8,388
2006/2007 0 (0–0) 0 (0–13) 15 (0–40) 0 (0–0) 0 (0–19) 415 (105–725) 430 (0–619) 2,942
2007/2008 26 (18–33) 13 (0–28) 62 (36–88) 111 (38–185) 0 (0–12) 396 (69–723) 608 (182–879) 10,589
2008/2009 10 (0–21) 12 (0–25) 60 (29–91) 187 (94–279) 397 (303–491) 2,434 (1,975–2,893) 3,100 (2,622–3,579) 28,298
Average
over 10
seasonal
epidemics
(1999/2009)
16 15 31 109 184 1,603 1,956 17,908
Pandemic 2009/2010 77 (61–93) 30 (13–48) 29 (0–58) 46 (0–121) 313 (232–394) 116 (0–442) 612 (266–958) 15,845
The 95% confidence intervals for the influenza-attributed deaths by age category are given in brackets behind the point estimates. In the last two columns on the right-
side of the table for each year in the study period the total number of influenza-attributed deaths is given as well as the total years-of-life-lost attributed to influenza.
doi:10.1371/journal.pone.0031197.t002
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estimated considerably higher for Mexico; this suggests heteroge-
neity in pandemic mortality and its age distribution between
countries and regions, although different model choices may partly
account for the reported differences.
Our observation of 8 deaths by cardiomyopathy during the
pandemic in the 0–4 yrs of age, and 5 deaths by spinal muscular
atrophy – even if confirmed to be related to pandemic influenza
infection – cannot quantitatively explain our estimate of 77
pandemic deaths. Nevertheless, cardiomyopathy and spinal
muscular atrophy are not unlikely to be related to influenza.
Heart disease is a known complication of influenza and has also
been specifically reported for pandemic influenza A(H1N1) 2009
[32,33,34,35]; the observed 8 cases of cardiomyopathy may well
represent more deaths by cardiomyopathy in young children, since
autopsy after an unexplained death is not standard. Spinal
muscular atrophy is a neurological condition that can lead to
Figure 2. Total (a) number of deaths and (b) years-of-life-lost (YLL) attributed to influenza by age category for the pandemic (2009/
2010) and all other years included in this study (1999–2009). The horizontal black dotted lines indicate the average total number of deaths
and years-of-life-lost for the 10 seasonal epidemics in 1999–2009.
doi:10.1371/journal.pone.0031197.g002
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death from a respiratory infection during early childhood [36,37];
the disproportionate level of spinal muscular atrophy related
deaths seems to be in line with the reported 9 deaths with
neurological disorders out of a total of 65 laboratory-confirmed
pandemic deaths [27]. To what extent the disproportionate
number of intracerebral haemorrhage in neonates may be related
to pandemic influenza seems more speculative, but fluctuating
blood pressure by coughing caused by influenza might be an
explanation [38].
Mortality vs morbidity
Unlike two earlier Dutch studies on the impact of the pandemic
[8,39], we ignored the impact of influenza morbidity. In one of
these studies, the pandemic was compared to seasonal influenza
morbidity based on the GP-ILI-incidence [8] – the pandemic ILI-
incidence appeared to be most marked among 5–14 yrs of age –
but no analyses on severity of infection or mortality were
performed.
In the other Dutch study [39], we estimated the total disease
burden by pandemic mortality and morbidity in the Netherlands.
This study had some limitations when comparing the pandemic
with seasonal influenza. Firstly, the number of years-of-life-lost
during the pandemic – which covered around 40% of the total
estimated pandemic disease burden – was restricted to laboratory-
confirmed deaths reported and was thus probably underestimated.
Secondly, in this earlier study we assumed the same severity weight
per influenza case for seasonal and pandemic influenza; this
assumption may thus lead to over- or underestimation of the
disease burden due to pandemic influenza morbidity. To avoid
this issue in our current study we only included mortality as a
measure of influenza severity, since death as a final outcome
cannot be less or more severe. It can be expected though that less
or more severe influenza morbidity will be reflected in lower or
respectively higher mortality and consequently is at least partly
captured by our study results.
Limitations
Several methods can be used to estimate influenza deaths from
mortality data, like annual regression methods [40,41], weekly or
monthly regression models with mortality attributed to influenza
using a seasonal baseline [9,10], or using the association of
mortality with measured influenza activity [42]. Since we had
consistent weekly data on influenza activity and age-specific
mortality available for both the pandemic and the 10 preceding
seasonal epidemics, we chose for regression models associating
age-specific weekly mortality to influenza activity. In such models,
pathogens or factors other than influenza can still bias the modeled
association of mortality and influenza activity. To minimize this
possibility, we considered pathogens other than influenza for
inclusion in our models as well. However, during the pandemic
several pathogens other than influenza appeared to be detected
disproportionately often, probably due to increased diagnostic
testing to exclude H1N1 infection. In addition, some pathogens
(e.g. rhinovirus) showed an increasing trend of weekly counts in
recent years, possibly reflecting the implementation of new
diagnostic tests. As artificial increases in laboratory counts can
bias the modeled association of pathogens with mortality, we did
not include the data of most pathogens. The only pathogen we did
include was Respiratory Syncytial virus (RSV); RSV is known to
cause severe morbidity, especially in young children but also in
adults [14,15], and thus could possibly affect the estimates for
influenza-associated mortality. We did, however, adjust the RSV
data for the supposed artificial increase during the pandemic (see
methods section). In the years before the pandemic, the annual
number of RSV detections was stable, so biases by new diagnostic
tests seemed unlikely.
Nevertheless, our estimates for influenza mortality can be
affected by the way we chose to model the association of
mortality with influenza activity in the population; another study
[43] resulted in different influenza mortality estimates for some
years compared to the current study. Several explanatory
variables had been different in that other study, so we decided
to explore the impact of the selected explanatory variables on the
results of the current study. We found that replacing the ILI-
incidence in the models by influenza detections resulted in similar
mortality estimates for pandemic and seasonal influenza (Appen-
dix S2). However, the association of mortality and influenza
detections may have been biased due to enhanced testing during
the peak of the pandemic. Secondly, we found that the influence
of RSV and the hot/cold weather variables on the estimated
influenza-attributed mortality was minimal (Appendix S2). Our
use of seasonal variables and autocorrelation in the models should
have corrected for mortality caused by pathogens we did not
include, and other seasonal or possibly transient causes of
mortality.
Some consider mortality categories such as pneumonia/
influenza and respiratory/cardiovascular deaths more specific for
influenza than all-cause mortality [9,40]. On the other hand, such
mortality categories are less sensitive for influenza mortality, as
deaths due to influenza can be coded in other categories as well.
Also, differences in coding practice in time or between countries
have no influence on all-cause mortality. Nevertheless, as a
validation of our results we showed that using pneumonia/
influenza and respiratory/cardiovascular deaths in our models
resulted in the same pattern of low pandemic mortality compared
to seasonal influenza, with relatively high pandemic mortality in
the youngest age group.
Finally, the residual life expectancy that we used to estimate the
years-of-life-lost may be lower for people with underlying medical
conditions (who are more likely to die from influenza; the so called
‘‘harvesting effect’’), leading to a potential overestimation of years-
of-life-lost. In an earlier study on laboratory-confirmed pandemic
deaths, modifying the life expectancy based on reported
underlying disease resulted in a reduction of years-of-life-lost by
over a third [39]. Nevertheless, comparing the pandemic years-of-
life-lost with seasonal epidemics seems still appropriate, as also
during seasonal epidemics severe morbidity and thus mortality will
likely be higher in people with underlying medical conditions; this
is illustrated by a study on pediatric influenza cases in the US,
where a similar percentage of patients with underlying medical
conditions was reported for severe morbidity by seasonal and
pandemic influenza [44].
Conclusion
We found that the pandemic had an overall moderate impact
on mortality compared to the 10 preceding seasonal epidemics;
disproportionate mortality in young children was observed, as
opposed to low mortality in $75 yrs of age. This resulted in a far
below average total number of pandemic deaths compared to
seasonal influenza, but a total number of years-of-life-lost only
somewhat below average. To assess the impact of future
pandemics, attributing age-specific all-cause mortality to influenza
should be preferred above comparing laboratory-confirmed deaths
to historical estimates for seasonal influenza. For other countries
and continents, pandemic mortality should be estimated relative to
seasonal influenza as well, to assess the worldwide impact of the
2009 pandemic.
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